°Ç±¹´ëÇб³º´¿ø ´ëÇÑ°íÇ÷¾ÐÇÐȸ °íÇ÷¾ÐÇÕº´Áõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2020-02-01±³À°ÀÏÀÚ : 2020-02-01
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ´ë°´ç(3Ãþ)
±³À°ÁÖÁ¦ :
´ëÇÑ°íÇ÷¾ÐÇÐȸ °íÇ÷¾ÐÇÕº´Áõ¿¬±¸È¸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : Á¤º°
¿¬¶ôó : 02-565-3350
À̸ÞÀÏ :
ksh2@koreanhypertension.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-01 ´ë°´ç 14:10~14:25 Any Advice or Critics, Welcome! ÀÓ»óÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 14:25~14:40 Any Advice or Critics, Welcome! ±èÇöâ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 14:40~14:55 Any Advice or Critics, Welcome! Á¤¿íÁø(°¡ÃµÀÇ´ë)
Åä·Ð 02-01 ´ë°´ç 14:55~15:10 Panel Discussion Á¶»óÈ£, ÃÖö¿õ, Á¶ÀºÁÖ, ½Å¹Ì½Â, ¹Ú¼º¹Ì, Ȳ°æ±¹, ±èÀ念(ÇѸ²ÀÇ´ë, °í·ÁÀÇ´ë, °¡Å縯ÀÇ´ë, °¡ÃµÀÇ´ë, °í·ÁÀÇ´ë, ÃæºÏÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 15:10~15:35 Recent Trends in Hypertension Research ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 15:35~16:00 Recent Updates, focus on Hypertensive Complication À̼±±â(ÇѸ²ÀÇ´ë)
Åä·Ð 02-01 ´ë°´ç 16:00~16:20 Panel Discussion Á¤¿íÁø, Á¶»óÈ£, ±èÇöÁß, ÀÓ»ó¿±, ¹Ú»ó¹Î, ·ùµ¿¿, ÃÖÁ¤Çö, À±ÇöÁÖ(°¡ÃµÀÇ´ë, ÇѸ²ÀÇ´ë, °Ç±¹ÀÇ´ë, °í·ÁÀÇ´ë, ÇѸ²ÀÇ´ë, °¿øÀÇ´ë, ºÎ»êÀÇ´ë, Àü³²ÀÇ´ë)
ÈÞ½Ä 02-01 ´ë°´ç 16:20~16:40 Coffee Break ()
±³À°½Ã°£ 02-01 ´ë°´ç 16:40~16:55 SPLINT : BP Reduction and and HTN Outcomes ¿ÀÀç¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 16:55~17:10 SGL2 Inhibitor in Metabolic HTN ±è¹Ì³ª(°í·ÁÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 17:10~17:20 Panel Discussion ½ÅÁ¤ÈÆ, Á¶µ¿Çõ, ¹ÚÁø¼±, Çѵ¿ÈÆ, Á¶ÀÎÁ¤, Á¤Çý¹®(ÇѾçÀÇ´ë, °í·ÁÀÇ´ë, ¾ÆÁÖÀÇ´ë, ÇѸ²ÀÇ´ë, ÀÌÈÀÇ´ë, °æÈñÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 17:20~17:35 Registry, Old but New Direction ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 17:35~17:50 New Direction, but Harmony with Old ±è¼ºÇØ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 02-01 ´ë°´ç 17:50~18:00 Panel Discussion ¼¼®¹Î, ÀÌÂùÁÖ, Á¤¹ÌÇâ °ø¹Î±Ô, ÀÌÁÖÈñ, ÃÖÈ«¹Ì, ±è¿ìÇö, ±è°æÁø(°¡Å縯ÀÇ´ë, ¿¬¼¼ÀÇ´ë, ÇѸ²ÀÇ´ë, ¼øõÇâÀÇ´ë, ÃæºÏÀÇ´ë, ÇѸ²ÀÇ´ë, °í·ÁÀÇ´ë, ÀÌÈÀÇ´ë)